Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association.

Cognitive function is an important component of aging and predicts quality of life, functional independence, and risk of institutionalization. Advances in our understanding of the role of cardiovascular risks have shown them to be closely associated with cognitive impairment and dementia. Because many cardiovascular risks are modifiable, it may be possible to maintain brain health and to prevent dementia in later life. The purpose of this American Heart Association (AHA)/American Stroke Association presidential advisory is to provide an initial definition of optimal brain health in adults and guidance on how to maintain brain health. We identify metrics to define optimal brain health in adults based on inclusion of factors that could be measured, monitored, and modified. From these practical considerations, we identified 7 metrics to define optimal brain health in adults that originated from AHA's Life's Simple 7: 4 ideal health behaviors (nonsmoking, physical activity at goal levels, healthy diet consistent with current guideline levels, and body mass index <25 kg/m2) and 3 ideal health factors (untreated blood pressure <120/<80 mm Hg, untreated total cholesterol <200 mg/dL, and fasting blood glucose <100 mg/dL). In addition, in relation to maintenance of cognitive health, we recommend following previously published guidance from the AHA/American Stroke Association, Institute of Medicine, and Alzheimer's Association that incorporates control of cardiovascular risks and suggest social engagement and other related strategies. We define optimal brain health but recognize that the truly ideal circumstance may be uncommon because there is a continuum of brain health as demonstrated by AHA's Life's Simple 7. Therefore, there is opportunity to improve brain health through primordial prevention and other interventions. Furthermore, although cardiovascular risks align well with brain health, we acknowledge that other factors differing from those related to cardiovascular health may drive cognitive health. Defining optimal brain health in adults and its maintenance is consistent with the AHA's Strategic Impact Goal to improve cardiovascular health of all Americans by 20% and to reduce deaths resulting from cardiovascular disease and stroke by 20% by the year 2020. This work in defining optimal brain health in adults serves to provide the AHA/American Stroke Association with a foundation for a new strategic direction going forward in cardiovascular health promotion and disease prevention.

[1]  Arthur F Kramer,et al.  Fitness Effects on the Cognitive Function of Older Adults: A Meta-Analytic Study—Revisited , 2018, Perspectives on psychological science : a journal of the Association for Psychological Science.

[2]  Sandra E. Black,et al.  Vascular cognitive impairment , 2018, Nature Reviews Disease Primers.

[3]  Mary G. George,et al.  Clinical Performance Measures for Adults Hospitalized With Intracerebral Hemorrhage: Performance Measures for Healthcare Professionals From the American Heart Association/American Stroke Association , 2014, Stroke.

[4]  Dali Sun,et al.  A systematic review and dose-response meta-analysis of sleep duration and the occurrence of cognitive disorders , 2018, Sleep and Breathing.

[5]  Quincy M. Samus,et al.  Dementia prevention, intervention, and care , 2017, The Lancet.

[6]  E. Benjamin,et al.  Prevalence, Correlates, and Prognosis of Healthy Vascular Aging in a Western Community-Dwelling Cohort: The Framingham Heart Study , 2017, Hypertension.

[7]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[8]  Rebecca W. Stubbs,et al.  Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014 , 2017, JAMA.

[9]  Tong Li,et al.  Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 , 2017, The Lancet.

[10]  Lihui Zhao,et al.  Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare Costs: Forty-Year Follow-Up of the CHA Study (Chicago Heart Association Detection Project in Industry). , 2017, Circulation.

[11]  Kaplan Tsimané: Das gesündeste Volk der Welt , 2017, DMW - Deutsche Medizinische Wochenschrift.

[12]  S. Lehéricy,et al.  Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial , 2017, The Lancet Neurology.

[13]  M. Kivimäki,et al.  Atrial fibrillation as a risk factor for cognitive decline and dementia , 2017, European heart journal.

[14]  Michael Gurven,et al.  Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study , 2017, The Lancet.

[15]  J. Vaupel,et al.  Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: a cohort study , 2017, The Lancet.

[16]  J. Eng,et al.  Aerobic exercise promotes executive functions and impacts functional neural activity among older adults with vascular cognitive impairment , 2017, British Journal of Sports Medicine.

[17]  A. Rahmim,et al.  Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.

[18]  D. Lloyd‐Jones,et al.  Favorable Cardiovascular Health Is Associated With Lower Health Care Expenditures and Resource Utilization in a Large US Employee Population: THE BAPTIST HEALTH SOUTH FLORIDA EMPLOYEE STUDY , 2017, Mayo Clinic proceedings.

[19]  R. Arena,et al.  Preventing Bad and Expensive Things From Happening by Taking the Healthy Living Polypill: Everyone Needs This Medicine. , 2017, Mayo Clinic proceedings.

[20]  Ailiana Santosa,et al.  A better world towards convergence of longevity? , 2017, The Lancet.

[21]  Guangquan Li,et al.  Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble , 2017, The Lancet.

[22]  L. Zahn Aging and variability among immune cells. , 2017, Science.

[23]  C. Ash Small molecules to target parasite organelle. , 2017, Science.

[24]  R. Geocadin,et al.  Heart-Brain Axis: Effects of Neurologic Injury on Cardiovascular Function. , 2017, Circulation research.

[25]  M. Banach,et al.  Intensive LDL‐cholesterol lowering therapy and neurocognitive function , 2017, Pharmacology & therapeutics.

[26]  Eric E. Smith,et al.  Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2017, Stroke.

[27]  S. Lageman,et al.  National Institute of Neurological Disorders and Stroke , 2017 .

[28]  Sudha Seshadri,et al.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association , 2016, Hypertension.

[29]  Janet S. Wright,et al.  CDC Grand Rounds: A Public Health Approach to Detect and Control Hypertension. , 2016, MMWR. Morbidity and mortality weekly report.

[30]  Edo Richard,et al.  Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial , 2016, The Lancet.

[31]  J. Tyler,et al.  Epigenetics and aging , 2016, Science Advances.

[32]  W. Maziak,et al.  A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations. , 2016, Mayo Clinic proceedings.

[33]  L. Schneider,et al.  Defeating Alzheimer's disease and other dementias: a priority for European science and society , 2016, The Lancet Neurology.

[34]  Sharon S. Simon,et al.  Cognitive Effects of Intentional Weight Loss in Elderly Obese Individuals With Mild Cognitive Impairment. , 2016, The Journal of clinical endocrinology and metabolism.

[35]  F. Grodstein,et al.  Sleep Duration in Relation to Cognitive Function among Older Adults: A Systematic Review of Observational Studies , 2016, Neuroepidemiology.

[36]  C. Lewis,et al.  Blood Pressure Reactivity to Psychological Stress in Young Adults and Cognition in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2016, Journal of the American Heart Association.

[37]  M. Schumacher,et al.  Incidence of Dementia over Three Decades in the Framingham Heart Study. , 2016, The New England journal of medicine.

[38]  D. Dijk,et al.  Self-reported sleep duration and cognitive performance in older adults: a systematic review and meta-analysis. , 2016, Sleep medicine.

[39]  P. Rabinovitch,et al.  Healthy aging: The ultimate preventative medicine , 2015, Science.

[40]  Zhen Zhao,et al.  Establishment and Dysfunction of the Blood-Brain Barrier , 2015, Cell.

[41]  O. Franco,et al.  Association Between Atrial Fibrillation and Dementia in the General Population. , 2015, JAMA neurology.

[42]  Katherine M Flegal,et al.  Prevalence of Obesity Among Adults and Youth: United States, 2011-2014. , 2015, NCHS data brief.

[43]  V. Hachinski Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation. , 2015, Stroke.

[44]  R. Davisson,et al.  Angiotensin-II, the Brain, and Hypertension: An Update. , 2015, Hypertension.

[45]  D. Jacobs,et al.  Nocturnal Blood Pressure in Young Adults and Cognitive Function in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 2015, American journal of hypertension.

[46]  M. Pletcher,et al.  Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels? , 2015, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

[47]  A. Booth,et al.  Is air pollution associated with increased risk of cognitive decline? A systematic review. , 2015, Age and ageing.

[48]  J. Williamson,et al.  Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial. , 2015, JAMA.

[49]  Catharyn T. Liverman,et al.  Cognitive Aging: Progress in Understanding and Opportunities for Action. , 2015, Military medicine.

[50]  Thomas Wisniewski,et al.  Clearance systems in the brain—implications for Alzheimer disease , 2015, Nature Reviews Neurology.

[51]  D. Corella,et al.  Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial. , 2015, JAMA internal medicine.

[52]  Shannon M. Sisco,et al.  The role of early-life educational quality and literacy in explaining racial disparities in cognition in late life. , 2015, The journals of gerontology. Series B, Psychological sciences and social sciences.

[53]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.

[54]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[55]  R. Morimoto,et al.  The biology of proteostasis in aging and disease. , 2015, Annual review of biochemistry.

[56]  M. Carrillo,et al.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective , 2015, Alzheimer's & Dementia.

[57]  L. Fredman,et al.  Informal caregiving and its impact on health: a reappraisal from population-based studies. , 2015, The Gerontologist.

[58]  B. Hwang,et al.  Ozone, particulate matter, and newly diagnosed Alzheimer's disease: a population-based cohort study in Taiwan. , 2015, Journal of Alzheimer's disease : JAD.

[59]  T. Trikalinos,et al.  Do Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2015, Journal of General Internal Medicine.

[60]  David C. Anderson,et al.  Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial , 2014, The Lancet Neurology.

[61]  Eric E. Smith,et al.  Clinical performance measures for adults hospitalized with acute ischemic stroke: performance measures for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[62]  P. Greenland,et al.  Long-Term Blood Pressure Variability Throughout Young Adulthood and Cognitive Function in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2014, Hypertension.

[63]  Karen Bandeen-Roche,et al.  Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. , 2014, JAMA neurology.

[64]  D. Houston,et al.  Weight Change, Body Composition, and Risk of Mobility Disability and Mortality in Older Adults: A Population‐Based Cohort Study , 2014, Journal of the American Geriatrics Society.

[65]  S. Rubin,et al.  Older adults with limited literacy are at increased risk for likely dementia. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[66]  T. Wadden,et al.  Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. , 2014, Journal of the American Pharmacists Association : JAPhA.

[67]  Alyssa A. Gamaldo,et al.  Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis , 2014, BMC Public Health.

[68]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[69]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[70]  V. Wadley,et al.  The American Heart Association Life's Simple 7 and Incident Cognitive Impairment: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study , 2014, Journal of the American Heart Association.

[71]  J. Veerman,et al.  Does physical activity prevent cognitive decline and dementia?: A systematic review and meta-analysis of longitudinal studies , 2014, BMC Public Health.

[72]  S. Redline,et al.  Associations of objectively and subjectively measured sleep quality with subsequent cognitive decline in older community-dwelling men: the MrOS sleep study. , 2014, Sleep.

[73]  M. Pletcher,et al.  Early Adult to Midlife Cardiovascular Risk Factors and Cognitive Function , 2014, Circulation.

[74]  Michael E. Miller,et al.  Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. , 2014, JAMA internal medicine.

[75]  N. Wong Faculty Opinions recommendation of 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014 .

[76]  C. DeCarli,et al.  Associations between serum cholesterol levels and cerebral amyloidosis. , 2014, JAMA neurology.

[77]  M. Fornage,et al.  Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[78]  Theresa M. Beckie,et al.  Council on Cardiovascular and Stroke Nursing. , 2014, The Journal of cardiovascular nursing.

[79]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[80]  A. Newman,et al.  Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study , 2013, BMJ.

[81]  D. Mozaffarian,et al.  Better Population Health Through Behavior Change in Adults: A Call to Action , 2013, Circulation.

[82]  C. Iadecola,et al.  Hypertension: A Harbinger of Stroke and Dementia , 2013, Hypertension.

[83]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[84]  M. G. Estes,et al.  Fine Particulate Matter and Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort , 2013, PloS one.

[85]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[86]  Angela J. Deokar,et al.  Self-Reported Increased Confusion or Memory Loss and Associated Functional Difficulties Among Adults Aged ≥60 Years — 21 States, 2011 , 2013, MMWR. Morbidity and mortality weekly report.

[87]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[88]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[89]  D. Jacobs,et al.  Cardiovascular health through young adulthood and cognitive functioning in midlife , 2013, Annals of neurology.

[90]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[91]  M. Özkaya,et al.  Action to Control Cardiovascular Risk in Diabetes , 2013 .

[92]  M. Dichgans,et al.  Prevention of vascular cognitive impairment. , 2012, Stroke.

[93]  C. Brayne,et al.  What sleep characteristics predict cognitive decline in the elderly? , 2012, Sleep medicine.

[94]  Guojun Bu,et al.  Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[95]  C. Moy,et al.  Vascular risk factors and cognitive impairment in a stroke-free cohort , 2011, Neurology.

[96]  S. Ancoli-Israel,et al.  Association of sleep characteristics and cognition in older community-dwelling men: the MrOS sleep study. , 2011, Sleep.

[97]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[98]  C. Moy,et al.  Incident cognitive impairment is elevated in the stroke belt: The REGARDS Study , 2011, Annals of neurology.

[99]  V. Hachinski Stroke and Alzheimer disease: fellow travelers or partners in crime? , 2011, Archives of neurology.

[100]  F. Faraci Protecting against vascular disease in brain. , 2011, American journal of physiology. Heart and circulatory physiology.

[101]  G. Hankey,et al.  Body Adiposity in Later Life and the Incidence of Dementia: The Health in Men Study , 2011, Alzheimer's & Dementia.

[102]  K. Yaffe Preclinical Alzheimer disease: Prevention Holy Grail or Pandora's Box?: Comment on "Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia". , 2011, Archives of internal medicine.

[103]  S. Yusuf,et al.  Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies , 2011, The Lancet Neurology.

[104]  C. Iadecola The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia , 2010, Acta Neuropathologica.

[105]  B. Schreurs The effects of cholesterol on learning and memory , 2010, Neuroscience & Biobehavioral Reviews.

[106]  K. Yaffe,et al.  Defining successful aging: the importance of including cognitive function over time. , 2010, Archives of neurology.

[107]  A. Folsom,et al.  Associations of Obesity Measures with Subtypes of Ischemic Stroke in the ARIC Study , 2010, Journal of epidemiology.

[108]  Jeffrey N. Browndyke,et al.  Aerobic Exercise and Neurocognitive Performance: A Meta-Analytic Review of Randomized Controlled Trials , 2010, Psychosomatic medicine.

[109]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[110]  Kristine Yaffe,et al.  Promising strategies for the prevention of dementia. , 2009, Archives of neurology.

[111]  E. Benjamin,et al.  ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiova , 2009, Journal of the American College of Cardiology.

[112]  E. Benjamin,et al.  AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention , 2009, Circulation.

[113]  M. Kivipelto,et al.  Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later , 2009, Dementia and Geriatric Cognitive Disorders.

[114]  K Yaffe,et al.  Predicting risk of dementia in older adults , 2009, Neurology.

[115]  S. MacDonald,et al.  Serum total cholesterol, statins and cognition in non-demented elderly , 2009, Neurobiology of Aging.

[116]  K. Yaffe,et al.  The metabolic syndrome and development of cognitive impairment among older women. , 2009, Archives of neurology.

[117]  Lewis H Kuller,et al.  Midlife and late-life obesity and the risk of dementia: cardiovascular health study. , 2009, Archives of neurology.

[118]  Suzanne Craft,et al.  The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. , 2009, Archives of neurology.

[119]  L. Kalra,et al.  Cognitive function and hypertension , 2009, Journal of Human Hypertension.

[120]  R. Mayeux,et al.  Mediterranean diet and mild cognitive impairment. , 2009, Archives of neurology.

[121]  A. Scuteri,et al.  Impact of Fasting Glycemia and Regional Cerebral Perfusion in Diabetic Subjects: A Study With Technetium-99m-Ethyl Cysteinate Dimer Single Photon Emission Computed Tomography , 2009, Stroke.

[122]  S. Yusuf,et al.  Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo , 2008, The Lancet Neurology.

[123]  C. Bulpitt,et al.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.

[124]  Luc Vanhees,et al.  Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. , 2008, The Cochrane database of systematic reviews.

[125]  Kathleen Baynes,et al.  The measurement of everyday cognition (ECog): scale development and psychometric properties. , 2008, Neuropsychology.

[126]  F. Gomez-Pinilla,et al.  Brain foods: the effects of nutrients on brain function , 2008, Nature Reviews Neuroscience.

[127]  H. Beydoun,et al.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta‐analysis , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[128]  Miia Kivipelto,et al.  The Atorvastatin/Donepezil in Alzheimer’s Disease Study (LEADe): Design and baseline characteristics ⁎ ⁎ Roy W. Jones and Miia Kivipelto contributed equally to the content of the manuscript. , 2008, Alzheimer's & Dementia.

[129]  Blackwell Synergy Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis , 2008 .

[130]  Sudha Seshadri,et al.  Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study , 2007, The Lancet Neurology.

[131]  R. Mayeux,et al.  Hypertension and the risk of mild cognitive impairment. , 2007, Archives of neurology.

[132]  F. Hu,et al.  Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. , 2007, Archives of internal medicine.

[133]  Kaarin J Anstey,et al.  Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. , 2007, American journal of epidemiology.

[134]  E. Barrett-Connor An introduction to obesity and dementia. , 2007, Current Alzheimer Research.

[135]  Eileen Crimmins,et al.  Education and Cognitive Decline in Older Americans , 2007, Research on aging.

[136]  E. Gorospe,et al.  The risk of dementia with increased body mass index. , 2006, Age and ageing.

[137]  S. Black,et al.  National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards , 2006, Stroke.

[138]  Jon Andresen,et al.  Endothelial influences on cerebrovascular tone. , 2006, Journal of applied physiology.

[139]  Sudha Seshadri,et al.  Homocysteine and cognitive performance in the Framingham offspring study: age is important. , 2005, American journal of epidemiology.

[140]  M. M. Mielke,et al.  High total cholesterol levels in late life associated with a reduced risk of dementia , 2005, Neurology.

[141]  Kristine Yaffe,et al.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study , 2005, BMJ : British Medical Journal.

[142]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[143]  J. Seidell,et al.  Epidemiology of obesity. , 2002, Seminars in vascular medicine.

[144]  C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[145]  Richard Mayeux,et al.  Relation of plasma lipids to Alzheimer disease and vascular dementia. , 2004, Archives of neurology.

[146]  J. Gayet The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. , 2003, Journal of hypertension.

[147]  W. Jagust,et al.  Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. , 2003, The American journal of clinical nutrition.

[148]  Neil Chapman,et al.  Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. , 2003, Archives of internal medicine.

[149]  A. Hofman,et al.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.

[150]  Martin Pinquart,et al.  Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis. , 2003, Psychology and aging.

[151]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[152]  J. Jolles,et al.  Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. , 2002, American journal of epidemiology.

[153]  D. Lauderdale,et al.  Education, wealth, and cognitive function in later life. , 2002, The journals of gerontology. Series B, Psychological sciences and social sciences.

[154]  S. Laughlin,et al.  An Energy Budget for Signaling in the Grey Matter of the Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[155]  P. Luiten,et al.  Cerebral microvascular pathology in aging and Alzheimer's disease , 2001, Progress in Neurobiology.

[156]  H. Soininen,et al.  Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.

[157]  A. Folsom,et al.  Cardiovascular risk factors and cognitive decline in middle-aged adults , 2001, Neurology.

[158]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[159]  E. Falk,et al.  Homocysteine and atherothrombosis , 2001, Lipids.

[160]  C M Burchfiel,et al.  Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men: The Honolulu-Asia Aging Study , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[161]  R. Havlik,et al.  Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.

[162]  A. Hofman,et al.  Prevention of vascular dementia. , 1999, Alzheimer disease and associated disorders.

[163]  Catherine R. Harrison,et al.  Ageing, fitness and neurocognitive function , 1999, Nature.

[164]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[165]  Bridget Kelly,et al.  A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. , 1998, Archives of neurology.

[166]  W. Applegate,et al.  Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. , 1994, Archives of internal medicine.

[167]  D. Gelb,et al.  Clinical Dementia Rating , 1994, Neurology.

[168]  L. Ferrucci,et al.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. , 1994, Journal of gerontology.

[169]  J. Breitner,et al.  Detection of dementia in the elderly using telephone screening of cognitive status , 1993 .

[170]  B. L. Beattie,et al.  The Clock Test: A Sensitive Measure To Differentiate Normal Elderly from Those with Alzheimer Disease , 1992, Journal of the American Geriatrics Society.

[171]  浜田賀代子,et al.  老年期痴呆患者のスクリーニングにおけるThe modified mini-mental state (3MS) examination日本語版の有用性 , 1992 .

[172]  J. Blumenthal,et al.  Failure of exercise to reduce blood pressure in patients with mild hypertension. Results of a randomized controlled trial. , 1991, JAMA.

[173]  Anthony F Jorm,et al.  The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms , 1989, Psychological Medicine.

[174]  D J Madden,et al.  Improving aerobic capacity in healthy older adults does not necessarily lead to improved cognitive performance. , 1989, Psychology and aging.

[175]  H. Chui,et al.  The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.

[176]  U S Nayak,et al.  Balance in elderly patients: the "get-up and go" test. , 1986, Archives of physical medicine and rehabilitation.

[177]  D. C. Bradford,et al.  Age-related decrements in Stroop Color Test performance. , 1984, Journal of clinical psychology.

[178]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[179]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[180]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[181]  F F SAVERIO,et al.  [Cerebral circulation]. , 1954, Omnia therapeutica. Supplemento.